YHO-13351 free base

CAS No. 912288-64-3

YHO-13351 free base( YHO13351 free base | YHO 13351 free base )

Catalog No. M16546 CAS No. 912288-64-3

YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 Get Quote
5MG 72 Get Quote
10MG 110 Get Quote
25MG 200 Get Quote
50MG 335 Get Quote
100MG 500 Get Quote
500MG 1098 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    YHO-13351 free base
  • Note
    Research use only, not for human use.
  • Brief Description
    YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
  • Description
    YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo; YHO-13351 is rapidly converted into YHO-13177 after its oral or intravenous administration, significantly increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppressed the tumor growth in an HCT116/BCRP xenograft model coadministration of irinotecan.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    YHO13351 free base | YHO 13351 free base
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    BCRP
  • Recptor
    BCRP
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    912288-64-3
  • Formula Weight
    483.6229
  • Molecular Formula
    C26H33N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 30 mg/mL
  • SMILES
    CCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)C=C(C#N)C3=CC(=C(C=C3)OC)OC
  • Chemical Name
    Glycine, N,N-diethyl-, 1-[5-[(1Z)-2-cyano-2-(3,4-dimethoxyphenyl)ethenyl]-2-thienyl]-4-piperidinyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yamazaki R, et al. Mol Cancer Ther. 2011 Jul;10(7):1252-63.
molnova catalog
related products
  • CP-100356 hydrochlor...

    CP-100356 hydrochloride is an orally active, low micromolar dual inhibitor of MDR1 (P-gp) and BCRP, a nucleotide-derived substrate analogue that inhibits MDR1-mediated Calcein-AM and BCRP-mediated Prazosin transporters.

  • Ko-143

    A nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM.

  • YHO-13177

    YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.